Entering text into the input field will update the search result below

Weekly Outlook, 5-8

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Seeking Alpha Analyst Since 2010

I am currently a student. I use a mix of technical and fundamental analysis to arrive at investing prospects and then do in-depth analysis.
The market sold off this week on relatively high volume on fears about commodity prices. The irony of this is twofold. First, lower commodity prices will benefit everyone except producers: It isn't bad for the economy. Second, the sell-offs are only as harsh as they need to be. Oil prices should stabilize, and silver prices need to fall after their meteoric rise. The market is now at support at 1375.
Meanwhile, my portfolio had a decent week. NRG was down a little bit, but it had a good 1st quarter [barring the priorly mentioned end to the STP 3&4 nuclear plant]. Guess failed to break through resistance at $43, but it should break through. It is in the middle of a huge symmetrical triangle formation, and I expect an upside breakout eventually. Eli Lilly may be on the cusp of a breakout of a 10-year downtrend and a 2-year range. Volume is high, and the bollinger bands predict a big upside breakout. I am very bullish. Astrazeneca is flirting with support/resistance at $50.75, which it has yet to decisively break either way. Bank of America continues to bumble along support. True Religion continues to outperform, even though it had a rough week. Overall, I'm bullish.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.